ADENOCARD LIQ IV 3MG/ML
ADENOCARD LIQ IV 3MG/ML
Discontinued
DIN Number
02030306
Drug Class
Human
Market Date
Dec 31, 1993
Company
HC
fujisawa pharmaceutical co, division of fujisawa canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02030306
AIG Number0113219001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C01EB10 ADENOSINE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification24:04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ADENOSINEActive
Strength: 3 MG / ML
Monograph: ADENOSINE